Literature DB >> 20609558

[Thrombotic thrombocytopenic purpura mediated by an ADAMTS13-inhibitor related to a treatment with pegylated-interferon alpha-2a and ribavirine in a patient with chronic hepatitis C].

Frédéric Lambot1, Bernard Hanson, Bernard Sztern.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20609558     DOI： 10.1016/j.lpm.2010.04.016

Source DB:  PubMed          Journal:  Presse Med        ISSN： 0755-4982            Impact factor:   1.228


× No keyword cloud information.
  2 in total

1.  Determination of ADAMTS13 and Its Clinical Significance for ADAMTS13 Supplementation Therapy to Improve the Survival of Patients with Decompensated Liver Cirrhosis.

Authors:  Masahito Uemura; Yoshihiro Fujimura; Saiho Ko; Masanori Matsumoto; Yoshiyuki Nakajima; Hiroshi Fukui
Journal:  Int J Hepatol       Date:  2011-07-18

2.  Thrombotic thrombocytopenic purpura in a patient with interferon treated hepatitis C successfully treated with rituximab.

Authors:  Nishant Poddar; Jen C Wang
Journal:  Hematol Rep       Date:  2013-01-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.